Navigation Links
Orexigen Therapeutics to Present at Upcoming Investor Conferences
Date:2/7/2013

SAN DIEGO, Feb. 7, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor conferences. The details are as follows:The 15th Annual BIO CEO & Investor Conference Date:

Tuesday, February 12, 2013Time:

2:00 p.m. Eastern TimeLocation:

The Waldorf Astoria, New York2013 Leerink Swann Global Healthcare Conference Date:

Wednesday, February 13, 2013Time:

11:30 a.m. Eastern Time Location:

The Waldorf Astoria, New YorkThe BIO CEO & Investor Conference presentation will be webcast live. To access the webcast, please visit the Investor Relations section of the company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.

Orexigen Contact: McDavid Stilwell
VP, Corporate Communications and Business Development 
(858) 875-8629

Media Contact: Denise Powell
BrewLife
(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... California , July 30, 2014 ... technology and CUDA programming expertise to big data, ... markets  eInfochips, a leading engineering R&D ... clients to develop NVIDIA GPU-powered solutions for ... high-performance computing (HPC), industrial , ...
(Date:7/29/2014)... 2014  Express Scripts Holding Company (Nasdaq: ... to Express Scripts stockholders of $515.2 million, or $0.67 ... detailed in Table 4, was $1.23 for the second ... to serve our clients with scale, alignment and innovative solutions ... health outcomes of our members," stated George Paz, chairman and ...
(Date:7/29/2014)... , July 29, 2014  EnteroMedics Inc. (NASDAQ: ... using neuroblocking technology to treat obesity, metabolic diseases and ... a conference call on Thursday, August 7, 2014 at ... the second quarter ended June 30, 2014 and to ... The second quarter conference call may be ...
Breaking Medicine Technology:eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 18Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 19Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 20Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 21Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 22Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 23Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 24Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 26Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 27Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 28Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 29Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 30Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 31EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3
... June 21, 2011 Enox Biopharma, Inc. CEO, John C. ... Innovation Conference on Wednesday, June 22 at 12:15 AM EST. ... in Boston. The IN3 East meeting, hosted ... The meeting is designed to provide exposure and constructive interaction ...
... MOUNT LAUREL, N.J., June 21, 2011 ImpactRx, ... on physician prescribing behavior announced that Kjell Nygren, ... Analytical Services.  Kjell will strengthen the company,s position ... address clients, needs for better understanding the effectiveness ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2ImpactRx Names Kjell Nygren Vice President, Analytical Services 2
(Date:7/30/2014)... BuyCBDOnline.co , the web's leading retailer ... announce that it is has made available through their ... available for immediate shipping. , "We have to remember ... site founder Jason Liss says. "For being such a ... unique products that are available or will be available ...
(Date:7/30/2014)... The Independent Woman , a leader in ... financial workshops in the Dallas area, August 20th - ... with significant input and guidance from Kim Kiyosaki, a highly ... out of life. More time, more money, and more freedom ... key to these goals. “Money is no longer a man’s ...
(Date:7/30/2014)... is often said the reason that most people are not as ... they only use about ten per cent of their total brain ... an erroneous myth propagated as an excuse by people who ... So, success in life is defined not just by one’s innate ... success. Thankfully, some people have finally figured out how to combine ...
(Date:7/30/2014)... City, OK (PRWEB) July 30, 2014 ... City, but it’s Founders, Amber Clour and Ryan Fightmaster ... worldwide level. , Officially launched on July 26th of ... provide real support for others living the diabetic life. ... had, dreams pursued and inspirations, they believe other diabetics ...
(Date:7/30/2014)... Seattle, Wa (PRWEB) July 30, 2014 According ... by Vkool.com, this is a comprehensive guide that will help ... quickly within a few weeks. This book uncovers to readers ... candida infection. In addition, inside this book, people will discover ... yeast infection such as itching, burning, and irritation of ...
Breaking Medicine News(10 mins):Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:The Independent Woman Will Offer Financial Workshops Developed by Women for Women in the Dallas Area 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3
... Samples from a poultry in Surat district of Gujarat has ... resumption of culling operations on chickens, around this area, according ... of bird flu among humans have been detected. The results ... to a lab in Bhopal.,Culling operations have started in these ...
... a mosquito-borne disease for which there is no known cure ... inhabitants of La Reunion Island // on Indian Ocean. As ... announced Xavier Bertrand, French Health Minister. ,More than ... 77 mortalities could be related directly or indirectly to the ...
... antigen is a tumor marker, elevated level of which ... is routinely used by doctors to spot early signs of ... suggested that a different criterion may be needed for establishment ... 70 years of age. ,The researchers from Duke ...
... a potential post-operative complication following coronary artery bypass grafting ... a new study has found. // The results ... in Anesthesiology journal. ,The researchers successfully administered ... undergoing CABG. This revolutionary technique could eventually pave way ...
... teeth by way of discoloring them, it also leads to ... to a new study // appearing in the April issue ... findings substantiate what most of us already know: Smoking is ... at the Boston VA Hospital and professor in the department ...
... A retired doctor fond of gambling lost pounds 8million in a ... one is // that he is putting the blame on ... is suing for his money back. ,The name of ... drugs giant GlaxoSmithKline had failed to warn patients its medicine Requip ...
Cached Medicine News:
... smartest choice , ... event is to ... environment. But will the device be durable enough? Can ... on its signal quality? Will the battery last? Is it comfortable, ...
... ideal as a primary chemistry-immuno analyzer ... laboratories or as a dedicated specialty ... consolidate chemistry-immuno testing with Olympus 122 ... specific proteins, esoteric chemistries and tests ...
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Medicine Products: